Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Dr. Daniel R Saltzstein , MD

Urology • San Antonio, TX

Active NPI 1922088947 Individual Practitioner Male Practitioner Accepts Medicare assignment
Practice location in NPPES

18915 Meisner Dr
San Antonio, TX 782584223

Call 2104995158 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

18915 Meisner Dr

San Antonio, TX 782584223

Telephone 2104995158
Fax 2106793730
Organization at the Same NPPES Address or Phone
Urology San Antonio Pa Facility NPI 1336551126

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Other Listings in Public Data

CMS Doctors and Clinicians lists 2 distinct group names: Urology Partners Of North Texas, Pllc; Urology San Antonio P A. See the list

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

Listings do not confirm current availability, employment or a shared ownership network.

Medicare Profile & Education

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Medical School

University Of Texas Medical School At San Antonio

Graduation Year

1986

Medicare patients

1,143 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.

Medicare-allowed amount

About $502,517 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

Paid by Medicare

About $397,356 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

30-day fills

10,132 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$9,678,484 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $54,335.52 across 91 records.

By nature of payment (3 largest of 6)

  • Consulting Fee: $27,328.75 across 13 records.
  • Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $19,679.00 across 7 records.
  • Travel and Lodging: $2,903.66 across 10 records.

Reporting-company totals (3 largest of 20)

  • Janssen Pharmaceuticals, Inc: $14,054.41 across 14 records.
  • Pfizer Inc.: $7,018.15 across 12 records.
  • Astellas Pharma US Inc: $6,392.72 across 3 records.

Research and ownership records are not included in these totals; they are in the table below.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

Years since graduation

40 years (graduated 1986)

CMS Doctors and Clinicians data list 1986 as the year this clinician finished professional school.

What this does not show: Years since graduation

It is not the number of years in practice, and more years does not mean better care.

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

NPI first issued

2006

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Accepts Medicare assignment

CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”

Guide: What Medicare assignment means

No telehealth indicator

CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Dr. Saltzstein has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Dr. Saltzstein as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in San Antonio and Texas

Billing and prescribing volume is not a quality rating.

Medicare Part B services

More Medicare Part B services than 95% of clinicians listed under Urology in San Antonio, TX (2024, 45 clinicians with data). Median for this group: 3,091. Middle half: 677 to 5,075.

More Medicare Part B services than 90% of clinicians listed under Urology in Texas (2024, 612 clinicians with data). Median for this group: 1,747. Middle half: 624 to 4,672.

Medicare-allowed amount

A higher Medicare-allowed amount than 95% of clinicians listed under Urology in San Antonio, TX (2024, 45 clinicians with data). Median for this group: $166,829. Middle half: $73,231 to $235,227.

A higher Medicare-allowed amount than 90% of clinicians listed under Urology in Texas (2024, 612 clinicians with data). Median for this group: $130,714. Middle half: $56,287 to $240,641.

Paid by Medicare

A higher Medicare payment amount than 95% of clinicians listed under Urology in San Antonio, TX (2024, 45 clinicians with data). Median for this group: $130,909. Middle half: $50,047 to $190,550.

A higher Medicare payment amount than 90% of clinicians listed under Urology in Texas (2024, 612 clinicians with data). Median for this group: $98,137. Middle half: $41,252 to $184,582.

Medicare Part D prescriptions

More Part D prescriptions than 95% of clinicians listed under Urology in San Antonio, TX (2024, 49 clinicians with data). Median for this group: 1,238. Middle half: 273 to 2,208.

More Part D prescriptions than 95% of clinicians listed under Urology in Texas (2024, 674 clinicians with data). Median for this group: 1,247. Middle half: 376 to 2,313.

Part D drug cost

A higher Part D drug cost than 95% of clinicians listed under Urology in San Antonio, TX (2024, 49 clinicians with data). Median for this group: $197,574. Middle half: $27,886 to $693,644.

A higher Part D drug cost than 95% of clinicians listed under Urology in Texas (2024, 674 clinicians with data). Median for this group: $145,258. Middle half: $28,676 to $353,758.

80 active clinicians are listed under Urology with a practice address in San Antonio, TX (968 in Texas).

Addresses are self-reported to NPPES and may be out of date.

Telehealth indicator in San Antonio

32.5% of these 80 clinicians have the CMS telehealth indicator.

62.5% of these 80 clinicians are listed by CMS as accepting Medicare assignment.

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo · Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments · Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 – December 31, 2025): 93 records totaling $55,605.52.

Manufacturer Payment Nature Product Type Amount ($)
Astellas Pharma US Inc
Consulting Fee
Cash or cash equivalent
Padcev General $6,360.00
Bayer Healthcare Pharmaceuticals Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
Nubeqa General $4,998.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
RYBREVANT General $4,162.50
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
RYBREVANT General $4,162.50
Sumitomo Pharma America, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
ORGOVYX General $3,575.00
Janssen Pharmaceuticals, Inc
Consulting Fee
Cash or cash equivalent
— General $3,191.25
Novartis Pharmaceuticals Corporation
Consulting Fee
Cash or cash equivalent
— General $2,700.00
Ferring Pharmaceuticals Inc.
Consulting Fee
Cash or cash equivalent
ADSTILADRIN General $2,415.00
UROGEN PHARMA, INC.
Honoraria
Cash or cash equivalent
ZUSDURI General $2,187.50
Novartis Pharmaceuticals Corporation
Consulting Fee
Cash or cash equivalent
— General $2,025.00
Telix Pharmaceuticals
Consulting Fee
Cash or cash equivalent
ILLUCCIX General $2,000.00
Pfizer Inc.
Consulting Fee
Cash or cash equivalent
— General $1,500.00
Pfizer Inc.
Consulting Fee
Cash or cash equivalent
— General $1,500.00
Pfizer Inc.
Consulting Fee
Cash or cash equivalent
TALZENNA General $1,500.00
Janssen Pharmaceuticals, Inc
Consulting Fee
Cash or cash equivalent
ERLEADA General $1,387.50
Telix Pharmaceuticals
Consulting Fee
Cash or cash equivalent
ILLUCCIX General $1,250.00
Bayer Healthcare Pharmaceuticals Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
Nubeqa General $1,176.00
Dendreon Pharmaceuticals LLC
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
PROVENGE General $1,050.00
Pfizer Inc.
Consulting Fee
Cash or cash equivalent
— General $1,000.00
Pfizer Inc.
General
In-kind items and services
XTANDI Research $940.00
Pfizer Inc.
Travel and Lodging
In-kind items and services
LORBRENA General $621.00
Telix Pharmaceuticals
Travel and Lodging
Cash or cash equivalent
ILLUCCIX General $612.08
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
RYBREVANT General $555.00
Pfizer Inc.
Consulting Fee
Cash or cash equivalent
— General $500.00
Novartis Pharmaceuticals Corporation
Travel and Lodging
In-kind items and services
PLUVICTO General $418.96

(top 25 shown)

Source: CMS Open Payments, program year 2025, released June 30, 2026.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B · Data Year 2024
Reporting Year:

CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
J0897 Injection, denosumab, 1 mg
4,620 27 $31.00 $25.09
87798 Detection test by nucleic acid for organism, amplified probe technique
1,224 80 $78.00 $34.39
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
1,149 763 $31.50 $15.56
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
929 591 $215.00 $120.58
81001 Manual urinalysis test with examination using microscope, automated
922 659 $15.00 $3.08
84153 Psa (prostate specific antigen) measurement, total
858 581 $110.00 $18.00
51798 Ultrasound measurement of bladder capacity after voiding
704 548 $95.00 $10.35
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
605 98 $102.00 $59.27
84403 Testosterone (hormone) level, total
490 273 $150.00 $25.29
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
322 294 $150.00 $85.41
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
182 117 $25.00 $6.34
80048 Blood test, basic group of blood chemicals (calcium, total)
181 113 $45.00 $8.29
36415 Insertion of needle into vein for collection of blood sample
173 152 $10.00 $8.55
52000 Diagnostic exam of bladder and urethra using an endoscope
118 104 $490.00 $222.56
87481 Detection test for candida species (yeast), amplified probe technique
102 80 $78.00 $34.39
87640 Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique
102 80 $78.00 $34.39
87653 Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique
102 80 $78.00 $34.39
80076 Liver function blood test panel
93 47 $45.00 $8.01
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
90 90 $313.00 $158.16
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
78 23 $700.00 $179.09
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
62 62 $210.00 $102.98
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
53 52 $290.00 $165.48
84154 Psa (prostate specific antigen) measurement, free
49 48 $150.00 $18.02
86316 Analysis for detection of tumor marker
49 48 $115.00 $20.39
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
45 39 $25.00 $7.61

(top 25 shown)

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D · Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Tamsulosin Hcl Tamsulosin Hcl 1,136 83,190 $17,145.80 308
Finasteride Finasteride 818 68,587 $11,091.72 241
Orgovyx Relugolix 644 19,304 $1,638,134.27 83
Erleada Apalutamide 275 8,280 $3,711,041.53 34
Myrbetriq Mirabegron 233 11,768 $176,938.36 68
Abiraterone Acetate Abiraterone Acetate 206 6,180 $419,723.66 23
Alfuzosin Hcl Er Alfuzosin Hcl 204 15,871 $3,935.26 52
Prednisone Prednisone 191 5,970 $1,160.40 23
Xtandi Enzalutamide 144 4,320 $1,986,912.17 23
Nitrofurantoin Nitrofurantoin Macrocrystal 127 7,345 $4,150.88 54
Oxybutynin Chloride Er Oxybutynin Chloride 124 6,840 $1,999.29 30
Ciprofloxacin Hcl Ciprofloxacin Hcl 117 1,572 $566.14 89
Trimethoprim Trimethoprim 92 5,610 $5,534.42 31
Cephalexin Cephalexin 90 5,593 $986.55 31
Nubeqa Darolutamide 83 2,490 $1,077,828.56 —
Testosterone Cypionate Testosterone Cypionate 81 6,067 $6,057.48 42
Tramadol Hcl Tramadol Hcl 75 184 $165.61 65
Oxybutynin Chloride Oxybutynin Chloride 71 3,267 $872.20 17
Potassium Citrate Er Potassium Citrate 63 4,549 $7,292.49 18
Gemtesa Vibegron 53 2,070 $32,284.74 14
Venlafaxine Hcl Er Venlafaxine Hcl 42 2,160 $484.64 —
Dutasteride Dutasteride 39 3,420 $1,009.05 11
Hydrochlorothiazide Hydrochlorothiazide 38 3,420 $132.04 12
Trelstar Triptorelin Pamoate 38 3,414 $94,187.27 13
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim 36 518 $252.06 34

(top 25 shown)

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Urology Primary Specialty

NUCC Taxonomy Code: 208800000X

License # reported to NPPES TX H2005

A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.

Surgery

NUCC Taxonomy Code: 208600000X

License # reported to NPPES TX H2005

A general surgeon has expertise related to the diagnosis - preoperative, operative and postoperative management - and management of complications of surgical conditions in the following areas: alimentary tract; abdomen; breast, skin and soft tissue; endocrine system; head and neck surgery; pediatric surgery; surgical critical care; surgical oncology; trauma and burns; and vascular surgery. General surgeons increasingly provide care through the use of minimally invasive and endoscopic techniques. Many general surgeons also possess expertise in transplantation surgery, plastic surgery and cardiothoracic surgery.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: Texas Medical Board.
Look Up on State Board Site

Additional State Medicaid & Healthcare Payer Identifiers

Medicaid ID
114697903 (TX)

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - UROLOGY

Medicare Enrollment ID

I20100416000534

Enrollment State Jurisdiction

TX

PECOS Control ID

5496641540

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Medicare Group Practice Enrollments

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Urology San Antonio P A

18915 Meisner Dr, San Antonio, TX 782584223

Phone: 2105825505

Urology Partners Of North Texas, Pllc

3301 Matlock Rd, Arlington, TX 760152908

Phone: 6825096200

Urology Partners Of North Texas, Pllc

5001 S Cooper St, Arlington, TX 760175993

Urology Partners Of North Texas, Pllc

7718 Pasteur Ct, San Antonio, TX 782293473

Phone: 2104479060

Urology Partners Of North Texas, Pllc

7909 Fredericksburg Rd, San Antonio, TX 782293400

Phone: 2106144544

Urology Partners Of North Texas, Pllc

945 Hilltop Dr, Weatherford, TX 760865892

Phone: 8663678768

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

6 listed
NPI 1396859039

Doctor of Medicine (M.D.)

Emily Haile , FNP

Nurse Practitioner - Family

NPI 1487293072

Family Nurse Practitioner

NPI 1932297157

Doctor of Medicine (M.D.)

Emily White , FNP

Nurse Practitioner - Family

NPI 1902887953

Family Nurse Practitioner

NPI 1295955086

Doctor of Osteopathic Medicine (D.O.)

Michelle Williams , PA-C

Physician Assistant

NPI 1194380188

Physician Assistant (Certified)

Career & Practice History Timeline

Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status

7 Historical Events
📍
Updated Practice Location October 08, 2018

Registered at 18915 MEISNER DR, SAN ANTONIO, TX 782584223 (Tel: 2104995158)

✅
NPI Profile Active April 11, 2014

NPI status registered as active in NPPES database

📍
Practice Location (Initial Record) April 11, 2014

Registered at 255 E SONTERRA BLVD, SUITE# 203, SAN ANTONIO, TX 782584075 (Tel: 2104995158)

📍
Business Mailing Address (Initial Record) April 11, 2014

Registered at 7909 FREDERICKSBURG RD, SUITE#110, SAN ANTONIO, TX 782293425 (Tel: 2106144544)

👤
Provider Name / Credentials (Initial Record) April 11, 2014

Recorded as DANIEL SALTZSTEIN, MD

🎓
Medical Taxonomy / Specialty Registered (Primary Specialty) April 11, 2014

Surgery (license number reported to NPPES: TX H2005)

🟢
Initial NPI Registration & Enumeration January 17, 2006

First registered as active Individual Practitioner in NPPES Database.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1922088947
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: January 17, 2006
Last Update: October 08, 2018
Sole Proprietor: No

Other Urology Specialists in San Antonio

All Urology Specialists in San Antonio

Mailing Address

7909 Fredericksburg Rd, Suite#110

San Antonio, TX 782293425

Phone: 2106144544

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.